Market cap
$171 Mln
Revenue (TTM)
$12 Mln
P/E Ratio
--
P/B Ratio
4.8
Div. Yield
0 %
| MediWound - ADR | Kamada - ADR | PolyPid (PYPD) | |
|---|---|---|---|
Market cap ($ Mln) |
171 | 475 | 104 |
Revenue ($ Mln) |
12 | 192 | -- |
Net Profit ($ Mln) |
-20.18 | 22.25 | -31.50 |
Net Margin (%) |
-170.10 | 11.60 | -- |
RoE (%) |
-50.91 | 8.26 | -385.07 |
Price to Earnings |
-- | 21.68 | -- |
Price-To-Book |
4.77 | 1.76 | 19.23 |
Cashflow ($ Mln)
| MediWound - ADR | Kamada - ADR | PolyPid (PYPD) | |
|---|---|---|---|
|
Cash From Operating Activities
|
-14.53 | 27.59 | -27.88 |
|
Cash Flow from Investing Activities
|
-19.54 | -10.65 | -- |
|
Cash from Financing Activities
|
29.62 | -19.86 | 25.37 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- |
Ratios
Profitability Ratios
| MediWound - ADR | Kamada - ADR | PolyPid (PYPD) | |
|---|---|---|---|
|
ROCE (%)
|
-53.14 | 7.33 | -219.95 |
|
ROE (%)
|
-50.91 | 8.26 | -385.07 |
|
ROA (%)
|
-19.14 | 4.47 | -84.05 |
|
EBIT Margin (%)
|
-176.09 | 13.90 | -- |
|
Net Margin (%)
|
-170.10 | 11.60 | -- |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | -- |
Growth Ratios
| MediWound - ADR | Kamada - ADR | PolyPid (PYPD) | |
|---|---|---|---|
|
Revenue Growth (%)
|
-40.26 | 13.17 | -- |
|
EBIT Growth (%)
|
23.20 | 36.69 | 49.74 |
|
Net Profit Growth (%)
|
28.53 | 17.05 | 8.76 |
|
EPS Growth (%)
|
39.18 | 11.11 | 61.30 |
|
Book Value Growth (%)
|
49.00 | 1.64 | -85.07 |
Valuation Ratios
| MediWound - ADR | Kamada - ADR | PolyPid (PYPD) | |
|---|---|---|---|
|
Price / Earnings
|
-9.91 | 21.55 | -2.62 |
|
Price / Book Value
|
5.43 | 1.62 | 8.14 |
|
Dividend Yield (%)
|
-- | -- | -- |
|
EV/EBITDA
|
-8.93 | 9.46 | -2.49 |
|
Market Cap ($ Cr)
|
-- | -- | -- |
Solvency Ratios
| MediWound - ADR | Kamada - ADR | PolyPid (PYPD) | |
|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.03 | 0.01 | 0.24 |
|
Current Ratio
|
2.32 | 4.06 | 1.35 |
|
Quick Ratio
|
2.09 | 2.29 | 1.14 |
|
Interest Coverage
|
-16.87 | 26.73 | -1,313.75 |
Operating Efficiency Ratios
| MediWound - ADR | Kamada - ADR | PolyPid (PYPD) | |
|---|---|---|---|
|
Debtors to sales (%)
|
29.44 | 19.13 | -- |
|
Asset Turnover
|
0.11 | 0.38 | 0.00 |
|
Receivable days
|
88.56 | 52.87 | -- |
|
Inventory Days
|
90.41 | 287.45 | -- |
|
Payable days
|
102.65 | 89.48 | -- |
|
Cash Conversion Cycle
|
76.33 | 250.84 | -- |